Stay updated on Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s revision label has been updated from v3.5.2 to v3.5.3, indicating a minor system/display update without changing the study details shown.
    Difference
    0.1%
    Check dated 2026-04-24T05:57:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:20:41.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:34:36.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and an older site-wide funding-status notice, along with Revision: v3.4.1, were removed; there are no changes to core study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:09:33.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page now displays a government funding status notice and an update to the revision (v3.4.1); these are informational and do not affect the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:21:49.000Z thumbnail image

Stay in the know with updates to Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib+CDK4/6 Inhibitor in Trastuzumab-Prior HER2+ Breast Ca Clinical Trial page.